Skip to main content

Month: August 2022

Apollo Senior Floating Rate Fund Inc. Declares August 2022 Monthly Distribution of $0.092 Per Share

NEW YORK, Aug. 12, 2022 (GLOBE NEWSWIRE) — (NYSE: AFT) – Apollo Senior Floating Rate Fund Inc. (the “Fund”) today announced the declaration of its distribution for the month of August 2022 of $0.092 per common share, payable on the date noted below. The following dates apply to the declared distribution: Ex-Date: August 22, 2022Record Date: August 23, 2022Payment Date: August 31, 2022Per Share Amount: $0.092 Apollo Contact Information: Product Literature877-864-4834 InvestorsElizabeth BesenInvestor Relations ManagerApollo Global Management, Inc.212-822-0625ebesen@apollo.com Forward-Looking StatementsThis press release may contain statements that are forward looking, as that term is defined by the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission in its rules, regulations and releases....

Continue reading

Hour Loop Reports Second Quarter 2022 Results

Demonstrates Strong Execution Despite Challenging Macroeconomic Environment and Unfavorable e-Commerce Traffic in Q2 Provides Full Year 2022 Revenue Guidance Range of $81 million to $90 million REDMOND, Wash., Aug. 12, 2022 (GLOBE NEWSWIRE) — Hour Loop, Inc. (NASDAQ: HOUR) (“Hour Loop”), a leading online retailer, announces its financial and operational results for the second quarter ended June 30, 2022. Financial Highlights for Second Quarter 2022:Total revenues increased 27.1% and 19.8% to $14.8 million, compared to $11.6 million in the year-ago period and $12.4 million for the first quarter of 2022, respectively. Net loss totaled $0.31 million, compared to net income of $1.1 million in the year-ago period and net loss of $0.65 million for the first quarter of 2022. Cash used in operating activities for the six months ended...

Continue reading

Beam Global Reports Fiscal Q2 2022 Financial Results

Conference Call Friday August 12, 2022 at 4:30 p.m. ET SAN DIEGO, Aug. 12, 2022 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM, BEEMW), (the “Company”), the leading provider of innovative sustainable products and technologies for electric vehicle (EV) charging, energy storage, energy security and outdoor media, today announced the financial results for the second fiscal quarter ended June 30, 2022. Fiscal Q2 2022 and Recent Company HighlightsGenerated the highest second quarter revenue in the company’s history of $3.7 million, a 75% increase over Q2 2021 Generated highest first half revenue in the company’s history of 7.5M, a 114% increase over first half 2021 Improved Gross Profitability in first half by 4% of revenue despite inflation Reduced net loss by over 14% of revenue in first half despite inflation and acquisition Grew...

Continue reading

Nova LifeStyle, Inc. Reports Second Quarter FY 2022 Results

LOS ANGELES, Aug. 12, 2022 (GLOBE NEWSWIRE) — Nova LifeStyle, Inc. (NASDAQ: NVFY) (“Nova LifeStyle” or the “Company”) today announced its financial results for the second quarter ended June 30, 2022. Key Financial Highlights: Operating Results for the Three Months Ended June 30, 2022Net sales for three months ended June 30, 2022 were $3.8 million, an increase of 7% from $3.5 million in the same period of 2021. Gross loss was ($3.5 million), compared to ($4 million) in the same period of 2021. Net loss was ($5.7 million), compared to ($6.3 million) loss in the same period of 2021.Operating Results for the Six Months Ended June 30, 2022Net sales for the six months ended June 30, 2022 were $7.5 million, an increase of 9% from $6.9 million in the same period 2021. Gross (loss) was ($2.0 million), compared to ($2.6 million) in...

Continue reading

Imago BioSciences Reports Second Quarter 2022 Financial Results and Provides Recent Business Updates

– Positive Data from the Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia (ET) Presented at European Hematology Association (EHA) Meeting 2022 – – Positive Data from the Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis Presented at EHA 2022 – – First Participant Dosed in Investigator-Sponsored Phase 1/2 Study of Bomedemstat in Combination with Atezolizumab in Small Cell Lung Cancer – – Obtained Advice from FDA Clinical Outcomes Assessment (COA) Group with Regard to Patient Reported Outcome (PRO) Endpoints for the Company’s Planned Phase 3 Trial of Bomedemstat in ET Patients – SOUTH SAN FRANCISCO, Calif., Aug. 12, 2022 (GLOBE NEWSWIRE) — Imago BioSciences, Inc. (“Imago” or the “Company”) (Nasdaq: IMGO), a clinical-stage biopharmaceutical company discovering...

Continue reading

Jasper Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

First patient dosed in a sponsored trial of JSP191 conditioning in patients with Fanconi Anemia On schedule to initiate a registrational study in AML in the first quarter of 2023 On schedule to initiate a new study of JSP191 as a therapeutic in second-line therapy for lower-risk, transplant ineligible MDS patients later this yearREDWOOD CITY, Calif., Aug. 12, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR), a biotechnology company focused on developing multiple new therapies for the field of stem and cellular medicine, today announced second quarter 2022 financial results and provided a corporate update. “During our second quarter, we continued to advance multiple clinical programs for our anti-CD117 monoclonal antibody, JSP191, announcing the first patient enrolled in a trial in Fanconi Anemia, advancing...

Continue reading

Nocopi Q2 Revenue Improves Modestly to $514,300 on Stronger License and Royalty Income

KING OF PRUSSIA, Pa., Aug. 12, 2022 (GLOBE NEWSWIRE) — Nocopi Technologies, Inc. (OTC Pink: NNUP), a developer of specialty reactive inks used in entertainment, toy and educational products as well as in document and product authentication technologies to combat fraud, today announced results for its second quarter ended June 30, 2022 (Q2 ’22). Nocopi’s SEC filings are available here. Q2’22 ResultsQ2’22 revenue increased to $514,300 as compared to Q2’21 revenue of $513,900, principally reflecting an increase in license and royalty revenue offset by a decrease in specialty ink purchases by Asia-based printers. Demand for Nocopi’s specialty ink offerings continues to be impacted by global supply chain challenges, including significant increases in international shipping costs, congestion at Chinese ports, as well as pandemic-related...

Continue reading

Winshear Increases Private Placement to $650,000

NOT FOR DISTRIBUTION IN THE U.S. VANCOUVER, British Columbia, Aug. 12, 2022 (GLOBE NEWSWIRE) — Winshear Gold (TSX-V: WINS) announces that, pursuant to the news release dated July 22, 2022, it has increased its non-brokered private placement financing to $650,000. The financing will now consist of up to 10,833,333 Units priced at 6c per Unit, whereby each Unit is comprised of one (1) common share of the Company and one half (1/2) warrant, whereby one full warrant entitles the holder to purchase one common share of the Company for 10c per common share at any time within 24 months of closing the financing. All shares issued will be subject to a 4 month plus one day hold period from the date of issuance. Completion of the private placement is subject to certain conditions, including the approval of the TSX Venture Exchange. All securities...

Continue reading

Atlantic American Corporation Reports Second Quarter Results for 2022

Net income of $1.2 million for the six month period ended June 30, 2022 Operating income of $4.4 million for the six month period ended June 30, 2022 Insurance premiums increased $3.1 million, or 9.5%, within the property and casualty operations for the six month period ended June 30, 2022ATLANTA, Aug. 12, 2022 (GLOBE NEWSWIRE) — Atlantic American Corporation (Nasdaq- AAME) today reported net loss for the three month period ended June 30, 2022 of $1.7 million, or $0.09 per diluted share, as compared to net income of $3.0 million, or $0.14 per diluted share, for the comparable period in 2021. For the six month period ended June 30, 2022, the Company reported net income of $1.2 million, or $0.05 per diluted share, as compared to net income of $2.5 million, or $0.11 per diluted share, for the comparable period in 2021. The decrease...

Continue reading

IQST – iQSTEL Higlights Material Information Discussed In Recent Management Interview

New York, NY, Aug. 12, 2022 (GLOBE NEWSWIRE) — iQSTEL, Inc. (OTCQX: IQST) today published material higlights of a management interview conducted yesterday, August 11, 2022. Alvaro Quintana, Tony Abdo and Leandro Iglesias were interviewed on Alpha Status Stocks by Michel Poarch.  Material highlights include: 1) The company plans to file the 10Q report for the period ended June 30, 2022 on Monday, August 15th. 2) The report is anticipated by management to show all positive trends consistent with corporate objectives: The $90 million 2022 annual revenue forecast reaching net Income positive performance by year end. 3) The company anticipates being close to break even in Q3 and reaching net income positive in Q4 and beyond. 4) The company plans to announce the forecast for 2023 in September. 5) Management reports that the company’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.